Search

everythinglearnresearchcommunity

for

Search:↓

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Prostaglandin analogs like Latanoprost might help grow hair on the scalp and body.

Upadacitinib effectively treats pyoderma gangrenosum.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

A new compound effectively inhibits human 5α-reductase 1.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Nutraceutical insulin-sensitizing agents may help treat skin conditions like psoriasis and acne.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Hair shedding is common in GLP-1 users, affecting treatment adherence.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Adding a second method to PROTACs could improve cancer treatment.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.